Leprosy, caused by the bacterium Mycobacterium leprae, is curable with multidrug therapy, yet early treatment is decisive. The disease damages peripheral nerves progressively, and every month of delay increases the risk of permanent disability, visible deformities and irreversible impairment of hands, feet and eyes. A timely diagnosis therefore depends not only on the availability of medicines but on how quickly a person with an unexplained skin lesion decides that biomedical care is worth pursuing. The Tanzanian study set out to map exactly that decision process, capturing how patients interpret symptoms, whom they consult first and what obstacles they meet along the way.

The researchers conducted a qualitative study using semi-structured interviews and focus group discussions with people affected by leprosy, community members, District Tuberculosis and Leprosy Coordinators, Community Health Workers and Prevention of Disability officers. Conversations were audio-recorded, transcribed and translated into English, then analyzed thematically to identify recurring patterns across the accounts. Ethical approval came from the Medical Research Coordinating Committee through the National Health Research Ethics Committee, and all participants gave written informed consent. Because some participants disclosed experiences of gender-based violence during the interviews, the team established referral procedures to link those individuals with appropriate support services.

The first major barrier the analysis uncovered is interpretive. Early symptoms of leprosy, such as pale or reddish patches of skin with reduced sensation, are frequently normalized as minor complaints or attributed to witchcraft and curses. In communities where such explanations carry deep cultural weight, the logical first step is not a clinic but a traditional healer. Consulting healers consumes time and household resources, and it frames the illness as a spiritual or social problem rather than a bacterial infection. By the time biomedical care is considered, the disease may have advanced considerably, and nerve damage that could have been prevented is already established.

The second barrier is social. Stigma surrounding leprosy remains powerful in the studied communities, rooted in centuries of fear of contagion and disfigurement. Participants described hesitation to disclose symptoms to anyone, including family members, because a visible skin patch could mark them as leprosy-affected and expose them to rejection, gossip or exclusion from social and economic life. When disclosure did occur, the advice received from relatives and neighbors often steered patients away from clinics, reinforcing the preference for traditional remedies or delaying the transition to biomedical care until symptoms became impossible to hide. Fear of rejection thus operates as a silent tax on every step of the care-seeking journey.

The third barrier lies within the health system itself. Even when patients eventually reach a facility, the study found that misdiagnosis is common. Frontline providers, particularly those who rarely encounter leprosy in routine practice, may mistake early lesions for fungal infections, eczema or other dermatological conditions. Limited provider familiarity with the disease means that suspicion of leprosy is often raised late, if at all, and patients are sent through repeated consultations before the correct diagnosis is confirmed. Each misdiagnosis adds weeks or months to a journey that already began with avoidable delays.

Referral delays compound the problem. Confirming leprosy requires clinical expertise and, in some settings, laboratory support that is concentrated at higher-level facilities. When the referral chain from a dispensary to a district hospital or specialized coordinator functions slowly, patients wait longer for confirmation and treatment initiation. The study also documented medicine shortages that interrupted the continuity of multidrug therapy, undermining both the effectiveness of treatment and patient confidence in biomedical services. Inadequate support for disability management, including prevention-of-disability counseling and care for existing impairments, further weakened the perceived value of seeking care early.

These three barriers do not operate in isolation; they interact and reinforce one another. A patient whose symptoms are attributed to witchcraft may avoid disclosure for fear of stigma, and when that patient finally presents at a clinic, a misdiagnosis can confirm the family’s skepticism about biomedical care. Health workers interviewed in the study described the frustration of seeing patients arrive with advanced nerve damage that earlier recognition would have prevented. District Tuberculosis and Leprosy Coordinators and Prevention of Disability officers emphasized that the system’s capacity to detect and manage leprosy is stretched thin, particularly in rural areas where the disease is now rare enough that many providers have never seen a case.

The authors argue that evidence-based interventions can break this cycle if they address all three barriers simultaneously. Culturally sensitive education campaigns can reframe early symptoms as treatable medical conditions without dismissing the spiritual beliefs that give them meaning, working through trusted community figures rather than against them. Stigma-reduction programs, including community-based awareness activities and the visible participation of people who have recovered from leprosy, can lower the social cost of disclosure and encourage earlier help-seeking. Strengthening frontline biomedical services means training providers to recognize leprosy, ensuring reliable supplies of multidrug therapy, and building referral systems that move suspected cases to confirmation quickly.

Policy efforts, the study concludes, should prioritize biomedical care alongside community-based awareness rather than treating the two as separate agendas. Reducing delays in leprosy diagnosis in Tanzania requires a health system that recognizes the disease when patients arrive, communities that view early care-seeking as safe and respectable, and education that reaches households before symptoms are explained away as curses. The qualitative evidence from Tanga and Morogoro offers a detailed map of where the journey to care breaks down, and it gives policymakers a concrete starting point for interventions that could spare future patients the disabilities that timely treatment would have prevented.

Subject of Research: Leprosy care-seeking barriers in Tanzania

Article Title: Barriers to biomedical care: Qualitative insights into health-seeking behaviors and systemic challenges among people affected by leprosy in Tanzanian communities

Article References: Muhigi, S. A., Mashoto, K., & Chiduo, M. (2026). Barriers to biomedical care: Qualitative insights into health-seeking behaviors and systemic challenges among people affected by leprosy in Tanzanian communities. PLOS Neglected Tropical Diseases, 20(10), e0014806. https://doi.org/10.1371/journal.pntd.0014806

Image Credits: AI Generated

DOI: 10.1371/journal.pntd.0014806

Keywords: leprosy, Tanzania, health-seeking behavior, stigma, neglected tropical diseases, qualitative research, Barriers, biomedical, care, Qualitative, insights, health-seeking